Sigma receptors as a pharmacological target for neuroprotectors. New horizons of pharmacotherapy of Parkinson disease

ISSN： 1819-7124

Source： Neurochemical Journal, Vol.5, Iss.2, 2011-06, pp. : 83-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

By Linazasoro G.

Journal of Neural Transmission, Vol. 115, Iss. 3, 2008-03 ,pp. : 431-441

Springer Publishing Company

Access to resources Recommend Favorite

Dual Target Identification and the Attentional Blink in Parkinson's Disease

By Vardy Yvette Bradshaw John L. Iansek Robert

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 25, Iss. 3, 2003-05 ,pp. : 361-375

Routledge Ltd

Access to resources Recommend Favorite

New Insights into Serotonin 5-HT4 Receptors : A Novel Therapeutic Target for Alzheimer's Disease?

Current Alzheimer Research, Vol. 1, Iss. 2, 2004-05 ,pp. : 79-85

Bentham Science Publishers

Access to resources Recommend Favorite

Mild cognitive impairment: new neuropsychological and pharmacological target

By Rivas-Vazquez Rafael A.

Archives of Clinical Neuropsychology, Vol. 19, Iss. 1, 2004-01 ,pp. : 11-27

Oxford University Press

Access to resources Recommend Favorite

New treatment of depression in Parkinson's disease

By Maruyama Tetsuhiro

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 25-27

Ashgate Publishing Ltd

Access to resources Recommend Favorite